Panel // Designing Resilient Farms: Building the Health Engine with Diagnostics, Vaccines, Genomics and AI

28 May 2026
Main Stage
Main Stage
  • How can diagnostics from passive tests to real-time decision engines that transform on-farm disease management?
  • What vaccine pipelines show the most promise across delivery methods, efficacy, and species-specific challenges (e.g. shrimp and non-salmon species)? Can vaccine innovation break species barriers?
  • How are selective breeding and genomic technologies driving growth, disease resistance, and welfare and where is the next wave of genetic breakthroughs beyond salmon?
  • How do we quantify welfare improvements tied to health and genetic interventions, and how does AI accelerate this process? Can welfare become a predictive measure for profitability?
  • How do we address antimicrobial resistance (AMR) as a real public health challenge, while linking solutions to prevention, diagnostics, vaccines, genetics, biosecurity, and data-driven decision‑making?
  • What pathways - training, financing, and partnerships - across academia, industry, and retail de-risk adoption and scale innovation? Which business models make health innovation financially viable?
Speakers
Andrew Swanson
Andrew Swanson, Vice President R&D - COOKE AQUA, Canada
Rishita Changede
Rishita Changede, Founder and CEO - TEORA, Singapore
John Buchanan
John Buchanan, CEO - CENTER FOR AQUACULTURE TECHNOLOGIES, Canada